[Myocardial reaction to adrenergic drugs during the early periods of development (review of the literature)].
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn; D002395:Catecholamines / Q000378:metabolism; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects* / Q000196:embryology / Q000254:growth & development; D006651:Histocytochemistry; D006801:Humans; D006892:Hydroxydopamines / Q000494:pharmacology; D051379:Mice; D008995:Monoamine Oxidase / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000502:physiology; D013565:Sympatholytics / Q000494:pharmacology*; D013566:Sympathomimetics / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D006892:Hydroxydopamines; D013565:Sympatholytics; D013566:Sympathomimetics; D012110:Reserpine; D011433:Propranolol; D008995:Monoamine Oxidase
Osobennosti reaktsii miokarda na adrenergicheskie sredstva v rannie periody razvitiia organizma (obzor literatury)